The rematch trial

Rationale, design, and end points

Eric A. Rose, Alan J. Moskowitz, Milton Packer, Josephine A. Sollano, Deborah L. Williams, Anita R. Tierney, Daniel F. Heitjan, Paul Meier, Deborah Davis Ascheim, Ronald G. Levitan, Alan D. Weinberg, Lynne Warner Stevenson, Peter A. Shapiro, Ronald M. Lazar, John T. Watson, Daniel J. Goldstein, Annetine C. Gelijns

Research output: Contribution to journalArticle

277 Citations (Scopus)

Abstract

Background. Because left ventricular assist devices have recently been approved by the Food and Drug Administration to support the circulation of patients with end-stage heart failure awaiting cardiac transplantation, these devices are increasingly being considered as a potential alternative to biologic cardiac replacement. The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial is a multicenter study supported by the National Heart, Lung, and Blood Institute to compare long-term implantation of left ventricular assist devices with optimal medical management for patients with end-stage heart failure who require, but do not qualify to receive cardiac transplantation. Methods. We discuss the rationale for conducting REMATCH, the obstacles to designing this and other randomized surgical trials, the lessons learned in conducting the multicenter pilot study, and the features of the REMATCH study design (objectives, target population, treatments, end points, analysis, and trial organization). Conclusions. We consider what will be learned from REMATCH, expectations for expanding the use of left ventricular assist devices, and future directions for assessing clinical procedures.

Original languageEnglish (US)
Pages (from-to)723-730
Number of pages8
JournalAnnals of Thoracic Surgery
Volume67
Issue number3
DOIs
StatePublished - Mar 1999
Externally publishedYes

Fingerprint

Heart Failure
Heart-Assist Devices
Heart Transplantation
Multicenter Studies
National Heart, Lung, and Blood Institute (U.S.)
Therapeutics
Health Services Needs and Demand
United States Food and Drug Administration
Organizations
Equipment and Supplies

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Rose, E. A., Moskowitz, A. J., Packer, M., Sollano, J. A., Williams, D. L., Tierney, A. R., ... Gelijns, A. C. (1999). The rematch trial: Rationale, design, and end points. Annals of Thoracic Surgery, 67(3), 723-730. https://doi.org/10.1016/S0003-4975(99)00042-9

The rematch trial : Rationale, design, and end points. / Rose, Eric A.; Moskowitz, Alan J.; Packer, Milton; Sollano, Josephine A.; Williams, Deborah L.; Tierney, Anita R.; Heitjan, Daniel F.; Meier, Paul; Ascheim, Deborah Davis; Levitan, Ronald G.; Weinberg, Alan D.; Stevenson, Lynne Warner; Shapiro, Peter A.; Lazar, Ronald M.; Watson, John T.; Goldstein, Daniel J.; Gelijns, Annetine C.

In: Annals of Thoracic Surgery, Vol. 67, No. 3, 03.1999, p. 723-730.

Research output: Contribution to journalArticle

Rose, EA, Moskowitz, AJ, Packer, M, Sollano, JA, Williams, DL, Tierney, AR, Heitjan, DF, Meier, P, Ascheim, DD, Levitan, RG, Weinberg, AD, Stevenson, LW, Shapiro, PA, Lazar, RM, Watson, JT, Goldstein, DJ & Gelijns, AC 1999, 'The rematch trial: Rationale, design, and end points', Annals of Thoracic Surgery, vol. 67, no. 3, pp. 723-730. https://doi.org/10.1016/S0003-4975(99)00042-9
Rose EA, Moskowitz AJ, Packer M, Sollano JA, Williams DL, Tierney AR et al. The rematch trial: Rationale, design, and end points. Annals of Thoracic Surgery. 1999 Mar;67(3):723-730. https://doi.org/10.1016/S0003-4975(99)00042-9
Rose, Eric A. ; Moskowitz, Alan J. ; Packer, Milton ; Sollano, Josephine A. ; Williams, Deborah L. ; Tierney, Anita R. ; Heitjan, Daniel F. ; Meier, Paul ; Ascheim, Deborah Davis ; Levitan, Ronald G. ; Weinberg, Alan D. ; Stevenson, Lynne Warner ; Shapiro, Peter A. ; Lazar, Ronald M. ; Watson, John T. ; Goldstein, Daniel J. ; Gelijns, Annetine C. / The rematch trial : Rationale, design, and end points. In: Annals of Thoracic Surgery. 1999 ; Vol. 67, No. 3. pp. 723-730.
@article{6d0debd2f51645f883a00685a83b3474,
title = "The rematch trial: Rationale, design, and end points",
abstract = "Background. Because left ventricular assist devices have recently been approved by the Food and Drug Administration to support the circulation of patients with end-stage heart failure awaiting cardiac transplantation, these devices are increasingly being considered as a potential alternative to biologic cardiac replacement. The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial is a multicenter study supported by the National Heart, Lung, and Blood Institute to compare long-term implantation of left ventricular assist devices with optimal medical management for patients with end-stage heart failure who require, but do not qualify to receive cardiac transplantation. Methods. We discuss the rationale for conducting REMATCH, the obstacles to designing this and other randomized surgical trials, the lessons learned in conducting the multicenter pilot study, and the features of the REMATCH study design (objectives, target population, treatments, end points, analysis, and trial organization). Conclusions. We consider what will be learned from REMATCH, expectations for expanding the use of left ventricular assist devices, and future directions for assessing clinical procedures.",
author = "Rose, {Eric A.} and Moskowitz, {Alan J.} and Milton Packer and Sollano, {Josephine A.} and Williams, {Deborah L.} and Tierney, {Anita R.} and Heitjan, {Daniel F.} and Paul Meier and Ascheim, {Deborah Davis} and Levitan, {Ronald G.} and Weinberg, {Alan D.} and Stevenson, {Lynne Warner} and Shapiro, {Peter A.} and Lazar, {Ronald M.} and Watson, {John T.} and Goldstein, {Daniel J.} and Gelijns, {Annetine C.}",
year = "1999",
month = "3",
doi = "10.1016/S0003-4975(99)00042-9",
language = "English (US)",
volume = "67",
pages = "723--730",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - The rematch trial

T2 - Rationale, design, and end points

AU - Rose, Eric A.

AU - Moskowitz, Alan J.

AU - Packer, Milton

AU - Sollano, Josephine A.

AU - Williams, Deborah L.

AU - Tierney, Anita R.

AU - Heitjan, Daniel F.

AU - Meier, Paul

AU - Ascheim, Deborah Davis

AU - Levitan, Ronald G.

AU - Weinberg, Alan D.

AU - Stevenson, Lynne Warner

AU - Shapiro, Peter A.

AU - Lazar, Ronald M.

AU - Watson, John T.

AU - Goldstein, Daniel J.

AU - Gelijns, Annetine C.

PY - 1999/3

Y1 - 1999/3

N2 - Background. Because left ventricular assist devices have recently been approved by the Food and Drug Administration to support the circulation of patients with end-stage heart failure awaiting cardiac transplantation, these devices are increasingly being considered as a potential alternative to biologic cardiac replacement. The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial is a multicenter study supported by the National Heart, Lung, and Blood Institute to compare long-term implantation of left ventricular assist devices with optimal medical management for patients with end-stage heart failure who require, but do not qualify to receive cardiac transplantation. Methods. We discuss the rationale for conducting REMATCH, the obstacles to designing this and other randomized surgical trials, the lessons learned in conducting the multicenter pilot study, and the features of the REMATCH study design (objectives, target population, treatments, end points, analysis, and trial organization). Conclusions. We consider what will be learned from REMATCH, expectations for expanding the use of left ventricular assist devices, and future directions for assessing clinical procedures.

AB - Background. Because left ventricular assist devices have recently been approved by the Food and Drug Administration to support the circulation of patients with end-stage heart failure awaiting cardiac transplantation, these devices are increasingly being considered as a potential alternative to biologic cardiac replacement. The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial is a multicenter study supported by the National Heart, Lung, and Blood Institute to compare long-term implantation of left ventricular assist devices with optimal medical management for patients with end-stage heart failure who require, but do not qualify to receive cardiac transplantation. Methods. We discuss the rationale for conducting REMATCH, the obstacles to designing this and other randomized surgical trials, the lessons learned in conducting the multicenter pilot study, and the features of the REMATCH study design (objectives, target population, treatments, end points, analysis, and trial organization). Conclusions. We consider what will be learned from REMATCH, expectations for expanding the use of left ventricular assist devices, and future directions for assessing clinical procedures.

UR - http://www.scopus.com/inward/record.url?scp=0032909782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032909782&partnerID=8YFLogxK

U2 - 10.1016/S0003-4975(99)00042-9

DO - 10.1016/S0003-4975(99)00042-9

M3 - Article

VL - 67

SP - 723

EP - 730

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 3

ER -